N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide

C22H23N5O3S — CID 655011

IUPACN-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide
SMILESO=C(Nc1ccc(S(=O)(=O)N2CCN(Cc3ccccc3)CC2)cc1)c1cnccn1
InChIInChI=1S/C22H23N5O3S/c28-22(21-16-23-10-11-24-21)25-19-6-8-20(9-7-19)31(29,30)27-14-12-26(13-15-27)17-18-4-2-1-3-5-18/h1-11,16H,12-15,17H2,(H,25,28)
InChIKeyWIYVPLMTDSOTHN-UHFFFAOYSA-N
MW437.53 g/mol
LogP2.24
Rot. Bonds6

About N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide

N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide (PubChem CID 655011) has the molecular formula C22H23N5O3S and a molecular weight of 437.53 g/mol. Its IUPAC name is N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide.

Molecular Properties

Compound NameN-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide
PubChem CID655011
Molecular FormulaC22H23N5O3S
Molecular Weight437.53 g/mol
Exact Mass437.15
IUPAC NameN-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide
SMILESO=C(Nc1ccc(S(=O)(=O)N2CCN(Cc3ccccc3)CC2)cc1)c1cnccn1
InChIInChI=1S/C22H23N5O3S/c28-22(21-16-23-10-11-24-21)25-19-6-8-20(9-7-19)31(29,30)27-14-12-26(13-15-27)17-18-4-2-1-3-5-18/h1-11,16H,12-15,17H2,(H,25,28)
InChIKeyWIYVPLMTDSOTHN-UHFFFAOYSA-N
XLogP2.24
TPSA95.50 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms31
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500437.53
LogP ≤ 52.24
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Glipizide
CID 3478
Azd2858
CID 10138980
4-(2-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulfonamide
CID 9883549
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]sulfamoyl}phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
CID 56962315
3-amino-6-(4-piperidin-1-ylsulfonylphenyl)-N-pyridin-3-ylpyrazine-2-carboxamide
CID 10138033
3-amino-N-[4-[(dimethylamino)methyl]-3-pyridinyl]-6-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazine-2-carboxamide
CID 10142642
N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide
CID 2608486
3-amino-6-[4-[2-(dimethylamino)ethyl-ethylsulfamoyl]phenyl]-N-pyridin-3-ylpyrazine-2-carboxamide
CID 10118131
3-amino-6-{3-fluoro-4-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-N-pyridin-3-ylpyrazine-2-carboxamide
CID 10301015
N-[(4-sulfamoylphenyl)methyl]pyrazine-2-carboxamide
CID 2466285
N-[1-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide
CID 4969032
5-methyl-N-[2-(2-methylanilino)-2-oxoethyl]-N-propylpyrazine-2-carboxamide
CID 25163734

Frequently Asked Questions

What is the IUPAC name of N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide?
The IUPAC name of N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide (CID 655011) is N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide.
What is the SMILES notation for N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide?
The canonical SMILES for N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide is O=C(Nc1ccc(S(=O)(=O)N2CCN(Cc3ccccc3)CC2)cc1)c1cnccn1.
What is the InChIKey of N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide?
The InChIKey is WIYVPLMTDSOTHN-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H23N5O3S/c28-22(21-16-23-10-11-24-21)25-19-6-8-20(9-7-19)31(29,30)27-14-12-26(13-15-27)17-18-4-2-1-3-5-18/h1-11,16H,12-15,17H2,(H,25,28).
What are the key properties of N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide?
N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide has a molecular weight of 437.53 g/mol, XLogP of 2.24, 6 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(4-benzylpiperazin-1-yl)sulfonylphenyl]pyrazine-2-carboxamide is sourced from PubChem (CID 655011), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).